GSK to buy cancer company for USD 1.9bn
![Photo: Toby Melville/REUTERS / X90004](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13920789.ece/ALTERNATES/schema-16_9/doc7kjlqn4ahlummcux11a.jpg)
Another acquisition is taking place in the pharmaceutical industry at large, as Glaxosmithkline (GSK) and Sierra Oncology have announced on Wednesday that they have reached an agreement, a press release reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Glaxosmithkline halts RSV trial after safety recommendation
For subscribers